Synthesis and anticonvulsant activity of some potential thiazolidinonyl 2-oxo/thiobarbituric acids

European Journal of Medicinal Chemistry

Volumn 41, Issue 10, 2006, Pages 1223-1229

  Agarwal, A ^a   Lata, S ^a   Saxena, K K ^a   Srivastava, V K ^a   Kumar, A ^a  

^a LLRM MEDICAL COLLEGE   (India)

Author keywords

Acute toxicity; Anticonvulsant activity; Iminoamino 2 oxo thiobarbituric acid; Thiazolidinonylamino 2 oxo thiobarbituric acid

Indexed keywords

ALDEHYDE; LAMOTRIGINE; PHENYTOIN; THIAZOLIDINE DERIVATIVE; THIOBARBITURIC ACID; THIOGLYCOLIC ACID; VALPROIC ACID; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; THIAZOLIDINONYL 2 OXOBARBITURIC ACID; THIAZOLIDINONYL 2 THIOBARBITURIC ACID; THIAZOLIDINONYL 2-OXOBARBITURIC ACID; THIAZOLIDINONYL 2-THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYCLOADDITION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; LD 50; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RAT; SEIZURE; TOXICITY TESTING; ANIMAL; COMPARATIVE STUDY; CYCLIZATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; SYNTHESIS;

ANIMALS; ANTICONVULSANTS; BARBITURATES; CYCLIZATION; DRUG EVALUATION, PRECLINICAL; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MOLECULAR STRUCTURE; SEIZURES; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; THIAZOLIDINES;

EID: 33749586733     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2006.03.029     Document Type: Article

References (14)

1. Goodman and Gilman's. The Pharmacological basis of Therapeutics (1996), McGraw-Hill Co., New York 471 (9th edi)
2. Goodman and Gilman's. The Pharmacological basis of Therapeutics (1996), McGraw-Hill Co., New York 472 (9th edi)
3. Archana S., Srivastava V.K., and Kumar A. Arzneim. Forsch/Drug Research. 52 (2002) 787-791
4. Goel B., Sharma S., Bajaj K., Bansal D., Singh T., Malik N., Lata S., Tyagi C., Panwar H., Agarwal A., and Kumar A. Indian J. Pharm. Sci. 67 (2005) 194-199
5. Osman A.N., Kandeel M.M., Ahmed M., and Indian S. J. Chem. 35B (1996) 1073-1078
6. Archana S., Rani P., Bajaj K., Chandora R., Srivastava V.K., and Kumar A. Arzneim. Forsch/Drug Research. 53 (2003) 301-306
7. Sarma G.V.S.R., Rao J.V., and Suresh B. Indian J. Pharm. Sci. 61 (1999) 105-109
8. Gupta K.P., Gupta R.C., Bhargava K.P., and Ali B. Eur. J. Med. Chem. 17 (1982) 448-452
9. Cesur N., Cesur Z., and Gursoy A. Arch. Pharm. (Weinheim Ger.) 325 (1992) 623-624
10. Chimirri A., Grasso S., Monforte A.M., Zappala M., De Sarro A., and Se Sarro G.B. Farmaco 46 (1991) 935-943
11. Archana S., Srivastava V.K., and Kumar A. Indian J. Pharm. Sci. 65 (2003) 358-362
12. Smith Q.E. Pharmacological screening tests progress in medicinal chemistry, 1 (1960), Butterworths, London 1-33
13. Tomon J.E.P., Swinyard E.A., and Goodman L.S. J. Neurophysiol. 9 (1946) 231-240
14. Fisher R.S. Brain Res. Rev. 14 (1989) 245-278